Patents by Inventor Qing Lin

Qing Lin has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20080138339
    Abstract: The present invention provides an anti-ovarian cancer bispecific antibody. Said antibody includes two polypeptide domains connected by a polypeptide linker, one is anti-ovarian cancer antibody, or its Fab fragment, single complementarity determining region (CDR) antibody or single chain Fv (scFv) and the other is anti-CD3 antibody, or its Fab fragment, single CDR antibody or scFv. The present invention also provides DNA sequences encoding said antibody, an expression vector containing said DNA sequence, and a host cell containing said expression vector.
    Type: Application
    Filed: August 22, 2007
    Publication date: June 12, 2008
    Inventors: Hualiang Huang, Xin Jiang, Min Fang, Jie Feng, Ping Zhou, Xiaocong Yu, Qing Lin
  • Publication number: 20080089228
    Abstract: A method to improve TCP throughput by separating TCP acknowledgment flow from TCP normal data flow in a wireless communications environment. This method creates dedicated signaling air interface link and signaling A10 link for TCP acknowledgment flow and assigns a higher priority value to TOS field of IP packets encapsulating TCP acknowledgments than those encapsulating TCP normal data.
    Type: Application
    Filed: February 28, 2007
    Publication date: April 17, 2008
    Applicant: HUAWEI TECHNOLOGIES, CO., LTD.
    Inventors: Qing Lin, Bin Gan, Xiaoyun Jing
  • Publication number: 20080075003
    Abstract: A method for controlling communications traffic on an inter-access-network link includes receiving a request for transmission of a traffic flow and determining a priority queue associated with the traffic flow. If the priority queue corresponds to the one of a first plurality of priority levels, the method further includes determining whether one or more predetermined criteria for the traffic flow are satisfied. If yes, the method additionally admitting the traffic flow, storing information associated with the traffic flow in the queue, and transmitting information associated with the traffic flow from the queue based on at least a strict priority process. If the queue corresponds to the one of a second plurality of priority levels, the method further admitting the traffic flow, storing information associated with the traffic flow in the queue, and transmitting information associated with the traffic flow from the queue based on at least an arbitrated priority process.
    Type: Application
    Filed: September 19, 2007
    Publication date: March 27, 2008
    Applicant: FutureWei Technologies, Inc.
    Inventors: Kuo-Chun Lee, Mazin Al-Shalash, Shuqing Xing, Jun Hu, Qing Lin, Ted Olawuyi, Hsien Woo, Thawatt Gopal
  • Patent number: 7347412
    Abstract: A modular picket fence including a pair of vertical posts positioned at suitable distance and adapted to be secured to a suitable support surface. A pair of horizontal upper and lower rails extend between and secured to the vertical posts. The upper rail has a plurality of apertures which are aligned with a plurality of apertures on the lower rail. The apertures can be of any given shape including square, narrow rectangular, wide rectangular, oval, round, narrow polygonal and wide polygonal. A plurality of vertical pickets having a cross-sectional shape corresponding to the shape of the apertures in the horizontal rails are respectively inserted through into aligned apertures of the upper and lower rails. The end portion of each vertical picket has two transverse apertures.
    Type: Grant
    Filed: September 9, 2005
    Date of Patent: March 25, 2008
    Inventor: Alan Qing-Lin Zhu
  • Publication number: 20080014377
    Abstract: Embodiments include floral picks for use with decorative foliage. One embodiment includes a floral pick including a body comprising a first body member and a second body member. The second member has a recess configured to receive the first body member. At least one wing includes a central portion positioned between the first body member and the second body member. A shaft is coupled to the body.
    Type: Application
    Filed: July 17, 2006
    Publication date: January 17, 2008
    Inventors: Case van Wingerden, Diana Filippin, Qing Lin
  • Publication number: 20070290583
    Abstract: A tool chest assembly includes a lower cabinet and an upper cabinet. The upper cabinet is configured to fit inside the lower cabinet during shipping or storage to save space. The tool chest assembly is configured for easy set-up and handling.
    Type: Application
    Filed: June 15, 2006
    Publication date: December 20, 2007
    Applicant: GEELONG SALES COMPANY INTERNATIONAL LTD.
    Inventors: Jon Fiscus, Darren Fraser, Qing Lin Xu
  • Patent number: 7262276
    Abstract: The present invention provides an anti-ovarian cancer bispecific antibody. Said antibody includes two polypeptide domains connected by a polypeptide linker, one is anti-ovarian cancer antibody, or its Fab fragment, single complementarity determining region (CDR) antibody or single chain Fv (scFv) and the other is anti-CD3 antibody, or its Fab fragment, single CDR antibody or scFv. The present invention also provides DNA sequences encoding said antibody, an expression vector containing said DNA sequence, and a host cell containing said expression vector.
    Type: Grant
    Filed: May 23, 2002
    Date of Patent: August 28, 2007
    Assignee: Beijing ABT Genetic Engineering Technology Co. Ltd.
    Inventors: Hualiang Huang, Xin Jiang, Min Fang, Xiaocong Yu, Jie Feng, Ping Zhou, Qing Lin
  • Publication number: 20070104000
    Abstract: The present invention according to certain embodiments is directed to a method, device and apparatus for repairing a plurality of memory locations. The present invention includes providing a plurality of memory locations, providing a plurality of fuses coupled to the memory locations and loading fuse data into a data register from a plurality of read-only memory (ROM) devices thereby creating loaded fuse data. The present invention also provides loading a programming sequence of the memory device, wherein the programming sequence includes a plurality of memory addresses, and reading the loaded fuse data from the fuse register to a plurality of memory locations corresponding to the plurality of memory addresses.
    Type: Application
    Filed: October 30, 2006
    Publication date: May 10, 2007
    Inventors: Qing Lin, Kiran Dasoju
  • Patent number: 6979563
    Abstract: A highly purified and specific glycosaminoglycan degrading enzyme, chondroitinase AC, and to a lesser extent, chondroitinase B, can be used in the treatment of metastatic cancers and in other disorders characterized by angiogenesis. The enzymatic removal of chondroitin sulfates A and C, and to a lesser extent, chondroitin sulfate B, from cell surfaces directly decreases the ability of tumor cells to invade blood vessels and thus prevents the formation of metastatic, or secondary tumors; inhibits tumor cell growth; and decreases angiogenesis by inhibiting both endothelial cell proliferation and capillary formation. Decreasing the formation of new blood vessels into the tumor in turn decreases the potential for tumor growth, and further decreases the ability of tumor cells to invade the bloodstream. These effects are opposite to the prometastatic effects of tumor-secreted heparanase.
    Type: Grant
    Filed: November 17, 2000
    Date of Patent: December 27, 2005
    Assignee: BioMarin Enzymes, Inc.
    Inventors: Elizabeth M. Denholm, Yong-Qing Lin, Paul J. Silver
  • Publication number: 20050255115
    Abstract: The present invention provides an anti-ovarian cancer bispecific antibody. Said antibody includes two polypeptide domains connected by a polypeptide linker, one is anti-ovarian cancer antibody, or its Fab fragment, single complementarity determining region (CDR) antibody or single chain Fv (scFv) and the other is anti-CD3 antibody, or its Fab fragment, single CDR antibody or scFv. The present invention also provides DNA sequences encoding said antibody, an expression vector containing said DNA sequence, and a host cell containing said expression vector.
    Type: Application
    Filed: May 23, 2002
    Publication date: November 17, 2005
    Inventors: Hualiang Huang, Xin Jiang, Min Fang, Jie Feng, Ping Zhou, Xiaocong Yu, Qing Lin
  • Publication number: 20050244467
    Abstract: Biodegradable implants sized and suitable for implantation in an ocular region or site and methods for treating ocular conditions. The implants provide an extended release of an active agent at a therapeutically effective amount for a period of time between 50 days and one year, or longer.
    Type: Application
    Filed: April 30, 2004
    Publication date: November 3, 2005
    Applicant: ALLERGAN, INC.
    Inventors: Thierry Nivaggioli, Jane Shiah, Qing Lin
  • Publication number: 20050175606
    Abstract: The invention provides a cyclic single-chain trispecific antibody against human tumor. It comprises three parts. The first part is an anti-tumor Fab antibody, an anti-tumor single-domain antibody or an scFv. The second part is a reshaped Fab antibody against human CD3, a reshaped single-domain antibody against human CD3 or a reshaped scFv against human CD3. The third part is a reshaped Fab antibody against human CD28, a reshaped single-domain antibody against human CD28 or a reshaped scFv against human CD28. The present invention also offers the DNA sequence coding for this trispecific antibody, expression vectors containing this DNA sequence and host cells (E. coli) containing the vectors.
    Type: Application
    Filed: April 10, 2002
    Publication date: August 11, 2005
    Inventors: Hua-Liang Huang, Ju-Long Cheng, Xiang-Bin Wang, Li-Ping Song, Zhong Zhang, Qing Lin, Ying Gu
  • Publication number: 20040018186
    Abstract: A highly purified and specific glycosaminoglycan degrading enzyme, chondroitinase AC, and to a lesser extent, chondroitinase B, can be used in the treatment of metastatic cancers and in other disorders characterized by angiogenesis. The enzymatic removal of chondroitin sulfates A and C, and to a lesser extent, chondroitin sulfate B, from cell surfaces directly decreases the ability of tumor cells to invade blood vessels and thus prevents the formation of metastatic, or secondary tumors; inhibits tumor cell growth; and decreases angiogenesis by inhibiting both endothelial cell proliferation and capillary formation. Decreasing the formation of new blood vessels into the tumor in turn decreases the potential for tumor growth, and further decreases the ability of tumor cells to invade the bloodstream. These effects are opposite to the pro-metastatic effects of tumor-secreted heparanase.
    Type: Application
    Filed: July 18, 2003
    Publication date: January 29, 2004
    Applicant: BIOMARIN ENZYMES INC.
    Inventors: Elizabeth M. Denholm, Yong-Qing Lin, Paul J. Silver
  • Publication number: 20030106240
    Abstract: A slipper includes a sole body having a plurality of apertures defined through the sole body and a plurality of protrusions extend from a top surface of the sole body. A skirt flange extends from a periphery of the bottom of the sole body and a plurality of notches are defined in a lower edge of the skirt flange. A plurality of cylindrical rods extend from the bottom of the sole body and share a common axis with the protrusions on the top surface of the sole body.
    Type: Application
    Filed: January 14, 2003
    Publication date: June 12, 2003
    Inventors: Jui-Te Wang, Kuo-Qing Lin, Dong-Jie Wei
  • Publication number: 20020088140
    Abstract: A sole for footwear includes a sole body having a plurality of protrusions extending from a top surface of the sole body so as to support the wearer's foot. A plurality of apertures are defined through said sole body and located between said protrusions.
    Type: Application
    Filed: January 10, 2001
    Publication date: July 11, 2002
    Inventors: Jui-Te Wang, Kuo-Qing Lin, Dong-Jie Wei